Avid Bioservices Inc (CDMO)

[jakedogman1]

oncologie news...

https://oncologie.international/oncologie-announces-first-patient-enrolled-in-global-phase-2-study-of-bavituximab-plus-keytruda-pembrolizumab-for-advanced-gastric-or-gastroesophageal-cancer/

“Initiating our first sponsored trial is a key milestone for Oncologie as it represents and highlights the progress we’ve made this year,” said Laura E. Benjamin, PhD, President and Chief Executive Officer at Oncologie. “This Phase 2 study is intended to further evaluate the antitumor activity and safety of bavituximab plus pembrolizumab in a gastric cancer population. We look forward to evaluating the potential this combination may provide globally.”

good reason for some IP questions at the ASM... milestone questions anyone... Laura thinks it's a milestone...

we know from contract payment due within 30 days of milestone achievement...

overall status of IP and relationship... manuf biz if any... etc...